Pyruvate dehydrogenase kinase 1–dependent metabolic reprogramming: A promising target for postmenopausal osteoporosis treatment
Postmenopausal osteoporosis (PMOP) is a classic endocrine disorder characterized by an imbalance between bone formation and bone resorption. Abnormal glucose metabolic reprogramming has been widely explored in endocrine disorders, but its role in PMOP has not been elucidated. Icariin (ICA), as a bio...
Main Authors: | Dingbang Xie, Yunteng Xu, Yimin Zhang, Wanping Cai, Xin Lan, Hui Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-04-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223001993 |
Similar Items
-
Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and Cancers
by: Nam Ho Jeoung
Published: (2015-06-01) -
Pyruvate dehydrogenase kinase regulates macrophage polarization in metabolic and inflammatory diseases
by: Chenyu Li, et al.
Published: (2023-12-01) -
Suppression of Pyruvate Dehydrogenase Kinase by Dichloroacetate in Cancer and Skeletal Muscle Cells Is Isoform Specific and Partially Independent of HIF-1α
by: Nives Škorja Milić, et al.
Published: (2021-08-01) -
A novel null mutation in the pyruvate dehydrogenase phosphatase catalytic subunit gene (PDP1) causing pyruvate dehydrogenase complex deficiency
by: Jirair K. Bedoyan, et al.
Published: (2019-07-01) -
Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer
by: Caroline E. Nunes-Xavier, et al.
Published: (2022-05-01)